Phase III COVID-19 vaccine trial halted after 'potentially unexplained illness'

Dr. Michael Osterholm said he'd be surprised if the illness was caused by the potential vaccine.
Author:
Updated:
Original:

A promising COVID-19 vaccine trial has been paused after a patient involved in the study fell ill. Biopharmaceutical company AstraZeneca announced Tuesday that a "standard review" led to the discovery of a "potentially unexplained illness." 

"This is a routine action which has to happen whenever there is a potentially unexplained illness in one of the trials, while it is investigated, ensuring we maintain the integrity of the trials," the statement said

AstraZeneca's Phase III trial involves 30,000 people in the United States, including Minnesota recipients through a partnership with HealthPartners Institute. The patient whose possible side effect that triggered the pause is from the United Kingdom. 

The third phase of the vaccine trial launched in early September, with the 30,000 adult patients receiving the potential vaccine or a placebo. The goal of the trial is to assess efficacy and safety of the drug while monitoring systemic and immune reactions. 

"The trial did exactly what it's supposed to do. If we see a potential health issue in one of the recipients, then we have to go ahead and determine if that's associated with the vaccine or if it's just a chance occurrence," said Dr. Michael Osterholm, infectious disease expert at the University of Minnesota, in a Wednesday appearance on WCCO Radio

Follow Bring Me The News on YouTube

Osterholm said the patient in the trial developed inflammation of the spinal cord, though Osterholm added that he "would be surprised if this is associated with the vaccine."

How long the trial will be paused is unclear. 

"We will be guided by this committee as to when the trials could restart, so that we can continue our work at the earliest opportunity to provide this vaccine broadly, equitably and at no profit during this pandemic," said Pascal Soriot, CEO of AstraZeneca. 

According to the Centers for Disease Control and Prevention, vaccine trials that pass Phase III can enter a fourth phase that features ongoing studies after the vaccine is approved and licensed. 

Next Up

Screen Shot 2021-01-16 at 6.53.17 PM

Mike Lindell's MyPillow offering discounts using the code 'Qanon'

The Shakopee-based company is under the microscope because of the recent actions of its owner.

Surly Brewing

Facing aluminum can shortage, Surly unveils solution: 'Cantyhose'

The brewery came up with a creative way to repurpose unused cans.

Liam Robbins

Gophers stay perfect at home by crushing 7th-ranked Michigan

Liam Robbins and Marcus Carr were too much for the previously undefeated Wolverines.

police lights

Four teens arrested over robberies in Minneapolis

They teens were found in a vehicle that was taken during an earlier carjacking.

Boundary Waters/BWCA

All BWCA visitors will now have to watch three 'Leave No Trace' videos

Visitors left an "unacceptably high amount" of damage last year.

ambulance

Ten fatal overdoses in past 6 weeks reported in region of northern MN

Law enforcement agencies have issued a plea to the general public.

u.s. district court minnesota - federal court minneapolis

Bracing for security threats, federal courthouses closing in Minnesota

Security is also being ramped up at the state capitol.

N95 mask

3M sues Florida company that sold 10K counterfeit N95 masks to HCMC

The Maplewood company has obtained a temporary injunction against the firm.

vaccine, covid

Walz, Whitmer, and Evers call on Trump Admin. to buy more vaccines

It comes after The Washington Post reported that the country's COVID vaccine reserves have been exhausted.

Related

coronavirus, coronavirus test, covid-19

Studies look at potential scenarios for COVID-19 in Minnesota

Osterholm said the coronavirus "is going to touch every family in Minnesota."

Screen Shot 2020-05-27 at 1.47.56 PM

COVID-19 fall peak? Osterholm not expecting a massive 2nd wave

The fall peak has long been dubbed a "worst-case scenario" by Dr. Osterholm.

coronavirus, covid-19

HealthPartners to join Oxford University COVID-19 vaccine trial

The Minnesota health system will enroll 1,500 people in the trial.

flu shot, vaccine

Pfizer seeks permission for emergency use of COVID-19 vaccine

The drug maker says its vaccine is 95% effective and ready to be deployed.

coronavirus, Iowa

Osterholm: Walz's restrictions could slow COVID-19 'maybe a little bit'

Osterholm believes much stricter mandates are needed to slow the pandemic.

flu shot, vaccine

Moderna says its COVID-19 vaccine appears to be 94.5% effective

It can be stored at a much warmer temperature than Pfizer's vaccine too.

dr. michael osterholm

Relief fund will support families of healthcare workers who died of COVID-19

Dr. Michael Osterholm has partnered with the St. Paul and Minnesota Foundation to launch the Frontline Families Fund.

Screen Shot 2020-05-27 at 1.47.56 PM

Osterholm reiterates COVID-19 going dormant could be bad signal

The infectious disease specialist has said this a few times now.